Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.

Ansari D, Aronsson L, Sasor A, Welinder C, Rezeli M, Marko-Varga G, Andersson R.

J Transl Med. 2014 Apr 5;12:87. doi: 10.1186/1479-5876-12-87. Review.

2.

Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.

Shukla HD, Mahmood J, Vujaskovic Z.

Cancer Lett. 2015 Dec 1;369(1):28-36. doi: 10.1016/j.canlet.2015.08.003. Epub 2015 Aug 11. Review.

PMID:
26276717
3.

Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.

Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA.

J Proteome Res. 2011 May 6;10(5):2359-76. doi: 10.1021/pr101148r. Epub 2011 Mar 28.

4.

Post-translational modifications of pancreatic fluid proteins collected via the endoscopic pancreatic function test (ePFT).

Paulo JA, Kadiyala V, Brizard S, Banks PA, Steen H, Conwell DL.

J Proteomics. 2013 Oct 30;92:216-27. doi: 10.1016/j.jprot.2013.01.033. Epub 2013 Mar 14.

5.

Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.

Pernikářová V, Bouchal P.

Expert Rev Proteomics. 2015;12(6):651-67. doi: 10.1586/14789450.2015.1094381. Epub 2015 Oct 10. Review.

PMID:
26456120
6.

Proteome-based biomarkers in pancreatic cancer.

Sun C, Rosendahl AH, Ansari D, Andersson R.

World J Gastroenterol. 2011 Nov 28;17(44):4845-52. doi: 10.3748/wjg.v17.i44.4845. Review.

7.

Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.

Zhu J, Nie S, Wu J, Lubman DM.

J Proteome Res. 2013 Jun 7;12(6):2791-804. doi: 10.1021/pr400139c. Epub 2013 May 29.

8.

Recent advances in mass spectrometry-based proteomics of gastric cancer.

Kang C, Lee Y, Lee JE.

World J Gastroenterol. 2016 Oct 7;22(37):8283-8293. Review.

9.

Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.

Coleman O, Henry M, McVey G, Clynes M, Moriarty M, Meleady P.

Expert Rev Proteomics. 2016;13(4):383-94. doi: 10.1586/14789450.2016.1167601. Review.

PMID:
26985644
10.

Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer.

Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, Lane Z, Crispin DA, Goodlett DR, Aebersold R, Bronner MP.

Mol Cell Proteomics. 2007 Aug;6(8):1331-42. Epub 2007 May 12.

11.

Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.

Boja ES, Fehniger TE, Baker MS, Marko-Varga G, Rodriguez H.

J Proteome Res. 2014 Dec 5;13(12):5325-32. doi: 10.1021/pr500753r. Epub 2014 Nov 18. Review.

12.

Pancreatic cancer: translational research aspects and clinical implications.

Ansari D, Chen BC, Dong L, Zhou MT, Andersson R.

World J Gastroenterol. 2012 Apr 7;18(13):1417-24. doi: 10.3748/wjg.v18.i13.1417.

13.

A functional proteomic method for biomarker discovery.

Reynolds F, Panneer N, Tutino CM, Wu M, Skrabal WR, Moskaluk C, Kelly KA.

PLoS One. 2011;6(7):e22471. doi: 10.1371/journal.pone.0022471. Epub 2011 Jul 19.

14.

Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape.

Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R, Brentnall TA.

Gastroenterology. 2005 Oct;129(4):1187-97.

PMID:
16230073
15.

Biomarkers for early diagnosis of pancreatic cancer.

Jenkinson C, Earl J, Ghaneh P, Halloran C, Carrato A, Greenhalf W, Neoptolemos J, Costello E.

Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):305-15. doi: 10.1586/17474124.2015.965145. Epub 2014 Nov 6.

PMID:
25373768
16.

Quantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex.

Kawahara T, Hotta N, Ozawa Y, Kato S, Kano K, Yokoyama Y, Nagino M, Takahashi T, Yanagisawa K.

PLoS One. 2013 Dec 5;8(12):e79654. doi: 10.1371/journal.pone.0079654. eCollection 2013.

17.

Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.

Ma H, Chen G, Guo M.

Proteomics Clin Appl. 2016 Apr;10(4):503-15. doi: 10.1002/prca.201500082. Epub 2016 Feb 3. Review.

PMID:
26616366
18.

Proteomic Approaches for Biomarker Panels in Cancer.

Tanase C, Albulescu R, Neagu M.

J Immunoassay Immunochem. 2016;37(1):1-15. doi: 10.1080/15321819.2015.1116009. Review.

PMID:
26565430
19.

[Will molecular diagnostics become established in pancreatic pathology?].

Sipos B, Sperveslage J.

Pathologe. 2013 Nov;34 Suppl 2:214-20. doi: 10.1007/s00292-013-1865-z. Review. German.

PMID:
24196616
20.

Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.

Guo J, Xie K, Zheng S.

Int J Biol Sci. 2016 Jan 28;12(3):292-301. doi: 10.7150/ijbs.14995. eCollection 2016. Review.

Supplemental Content

Support Center